Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBUMP.L Regulatory News (BUMP)

  • There is currently no data for BUMP

Trading Statement

23 Sep 2021 07:00

RNS Number : 6824M
Seraphine Group PLC
23 September 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

For immediate release

 

23 September 2021

 

Seraphine Group plc

("Seraphine" or the "Group")

 

Trading Update

 

Seraphine, an international digitally-led maternity and nursing wear brand, today provides an update on trading following its admission to the London Stock Exchange on 16 July 2021.

 

The Group experienced a strong Q1 (13 weeks to 4th July 2021) with better than expected demand for higher priced categories and delivered year on year Group revenue growth of greater than 50%. However, trading in the second quarter has been more challenging than the Board anticipated.

 

The Group, along with the wider market, experienced supply chain issues from China due to the heavily delayed arrival of sea freight from late July. Whilst these stock issues have now been fully resolved, this meant that the Group had a stock holding significantly below plan from late July through to the end of August and was unable to fully satisfy customer demand. As a result, the Group experienced a loss of momentum on its own digital platform as it exited the summer months, capturing fewer customers at the beginning of their maternity cycle. This resulted in marketing spend in the period being less effective due to the lower mix of returning customers in the key Q2 trading month of September. Digital Partnerships are performing well, with the second quarter benefiting from a full impact of the Zalando partnership, however the physical retail environment remains challenging for the Group's eight retail stores.

 

As a result the Group now expects H1 year on year revenue growth to be circa 35% on a constant currency basis (circa 30% on variable currency) and Adjusted EBITDA pre-IFRS16 to be circa £2.5m (circa 15% below previous year).

 

Looking ahead to the full year, should the recent trends continue, the Group would expect revenue growth to be at least in line with H1 and profit to be at least in line with FY21 (on an Adjusted EBITDA pre-IFRS16 basis).

 

The management team is implementing the following actions which could lead to an improved full year outturn:

 

· Marketing effectiveness: optimisation and redistribution of marketing spend in favour of demand creation channels to rebuild momentum

· Supply Chain / Logistics: building more time contingency into the design and supply process

· New market launches: the Group remains on track to launch a dedicated eCommerce site for the Netherlands in the coming weeks and to expand its Digital Partnership with Zalando into more Northern European Markets

 

David N Williams, CEO of Seraphine said:

 

"After a strong Q1 exceeding expectations with Group revenue growth of over 50%, it is extremely disappointing to have to report a weaker Q2 performance due to the significant impact of logistical headwinds and the subsequent momentum loss. I believe the actions we are taking are the right ones to ensure an improved second half performance and I remain fully confident in the future prospects for Seraphine."

 

The Board will provide a further update in the Group's Interim Results which are expected to be published in December 2021.

 

This announcement has been released by JTC (UK) Limited, Company Secretary on behalf of Seraphine.

 

Enquiries

 

For further information, please contact:

 

Seraphine Group plc

David N Williams, Chief Executive Officer

John Bailey, Finance Director

 

via FTI Consulting

FTI Consulting (PR adviser to Seraphine)

Alex Beagley

Fern Duncan

Rafaella de Freitas

 

+44 (0)20 3727 1000

Seraphine@fticonsulting.com

Numis Securities Limited (Broker to Seraphine)

Garry Levin

Tom Jacob

Jonny Abbott

William Wickham

 

+44 (0)20 7260 1205

 

About Seraphine

Seraphine is an international digitally-led maternity and nursing wear brand with a diverse range of innovative maternity and nursing products serving an under-competed global market.

 

Seraphine was founded in 2002 with the vision of creating desirable clothes which women would want to wear even if they were not pregnant, and this ethos remains true to this day. The Group has over 18 years' experience designing and developing maternity and nursing wear for women from first trimester to post-partum and nursing products.

 

The Group has achieved global brand recognition through its rapidly growing digital platform, which in the year to 4 April 2021, contributed to approximately 89% of revenue. The Group currently exports products to customers in over 120 countries globally, with the Group's largest markets being Europe, North America and the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDCUSDDGBD
12
Date   Source Headline
31st Mar 20237:00 amRNSUpdate on Acceptance Levels
27th Mar 202312:58 pmRNSNotification of Major Holdings
27th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20235:58 pmRNSPDMR Shareholding and Total Voting Rights
23rd Mar 20237:00 amRNSOffer Update - Notice of Offer Closing
9th Mar 20239:27 amRNSForm 8.3 - Seraphine Group PLC
8th Mar 20235:45 pmRNSSeraphine Group
8th Mar 202311:37 amRNSCancellation of Listing
8th Mar 20238:20 amRNSForm 8.3 - Seraphine Group PLC
8th Mar 20237:00 amRNSOffer Declared Unconditional
7th Mar 20237:00 amRNSUpdate on Acceptance Levels
1st Mar 20239:12 amRNSForm 8.3 - SERAPHINE GROUP PLC
28th Feb 20237:00 amRNSUpdate on Acceptance Levels
23rd Feb 20238:37 amRNSForm 8.3 - SERAPHINE GROUP PLC
21st Feb 20237:00 amRNSUpdate on Acceptance Levels
7th Feb 20238:27 amRNSForm 8.3 - Seraphine Group PLC
3rd Feb 202311:45 amRNSForm 8.3 - Seraphine Group plc
1st Feb 20233:29 pmRNSForm 8.3 - Seraphine Group Plc
1st Feb 20233:28 pmRNSForm 8.3 - Seraphine Group Plc
1st Feb 20233:24 pmRNSForm 8.3 - Seraphine Group Plc
1st Feb 202312:11 pmRNSForm 8 (OPD) - Seraphine Group PLC
1st Feb 20239:17 amRNSForm 8.3 – John Bailey
31st Jan 20233:06 pmRNSForm 8 (OPD) - Seraphine Group plc
30th Jan 20235:46 pmRNSPosting of Offer Document
30th Jan 20238:54 amRNSForm 8.3 - SERAPHINE GROUP PLC
27th Jan 20239:12 amRNSForm 8.3 - SERAPHINE GROUP PLC
26th Jan 20238:28 amRNSForm 8.3 - Seraphine Group PLC
25th Jan 20232:08 pmRNSForm 8.3 - Seraphine Group PLC
25th Jan 20238:43 amRNSForm 8.3 - SERAPHINE GROUP PLC
24th Jan 20238:36 amRNSForm 8.3 - Seraphine Group PLC
23rd Jan 20231:49 pmRNSForm 8.3 - Seraphine Group PLC
23rd Jan 202312:41 pmGNWForm 8.3 - [Seraphine Group plc - Opening Declaration - 20 01 2023] - (CGAML)
23rd Jan 20238:42 amRNSForm 8.3 - SERAPHINE GROUP PLC
20th Jan 20232:28 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Seraphine Group plc
20th Jan 202312:01 pmRNSForm 8.3 - Seraphine Group PLC
20th Jan 202310:56 amRNSForm 8.3 - SERAPHINE GROUP PLC
20th Jan 20237:00 amRNSRecommended Cash Offer
22nd Dec 20227:00 amRNSChange of Adviser
14th Dec 20224:38 pmRNSNotification of Major Holdings
8th Dec 20227:00 amRNSInterim Results
9th Nov 20227:00 amRNSCapital Reduction
8th Nov 20227:00 amRNSHalf Year Trading Update
30th Sep 20223:49 pmRNSDirector/PDMR Shareholding Grant of LTIP Awards
27th Sep 20222:36 pmRNSNotification of Major Holdings
21st Sep 20222:08 pmRNSResult of AGM
19th Aug 20224:30 pmRNSDirector/PDMR Shareholding
15th Aug 202212:49 pmRNSNotice of AGM and Annual Report and Accounts
3rd Aug 202211:29 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.